{"nctId":"NCT01954056","briefTitle":"Hydrocortisone for Term Hypotension","startDateStruct":{"date":"2014-06-19","type":"ACTUAL"},"conditions":["Infant, Newborn, Diseases","Cardiovascular Insufficiency"],"count":12,"armGroups":[{"label":"Hydrocortisone","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Hydrocortisone"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Hydrocortisone","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Gestational age greater than or equal to 34 weeks at birth\n* Admitted to the center NICU by 48 hours of age\n* Intubated and mechanically ventilated for a minimum of 2 hours before 72 hours postnatal age\n\nExclusion Criteria:\n\n* Receiving ECMO\n* Intubated for the sole purpose of anticipated surgery or airway anomalies\n* Treatment will be limited based on poor prognosis\n* Receiving dexamethasone or hydrocortisone\n* Receiving ibuprofen or indomethacin\n* Congenital heart disease\n* Hypotension thought to result from specific, immediately remediable factors including placental hemorrhage, acute hemorrhage or tension pneumothorax\n* Pituitary hypoplasia or congenital adrenal hyperplasia\n* Any chromosomal disorder\n* Hypertension in the absence of inotrope therapy as defined by mean arterial blood pressure \\> 95th percentile\n* Initiation of whole body cooling for moderate or severe neonatal encephalopathy\n* Brain disorders or any other known structural abnormality\n* Major anomalies","healthyVolunteers":false,"sex":"ALL","minimumAge":"34 Weeks","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Death","description":"This is measured as Yes if an infant died between birth and 22-26 months corrected gestational age; Otherwise, No.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"6","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"PRIMARY","title":"Number of Participants With Neurodevelopmental Impairment","description":"This is measured as Yes if an any hearing impairment or visual impairment is noted, if non-normal gross motor function level is noted, any seizures have been noted, or if the cognitive, language, or motor scores of the Bayley III score are more than 1 standard deviation below the average; Otherwise, No.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"3","spread":null}]},{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]}]},{"type":"PRIMARY","title":"Number of Participants With Death or Neurodevelopmental Impairment","description":"A composite outcome that measures the occurrence of death or neurodevelomental impairment between birth and 22-26 months corrected gestational age.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"3","spread":null}]},{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]}]},{"type":"SECONDARY","title":"Duration of Mechanical Ventilation","description":"This is measured as the number of days between birth and 60 days of life of mechanical ventialtion of laryngeal intubation.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"11","spread":null}]}]}]},{"type":"SECONDARY","title":"Days to Full Feeds","description":"The day of life at which full nipple feeds were reached between birth and 60 days of life. Full nipple feeds are defined as at least 120 mg/kg/day.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16","spread":null},{"groupId":"OG001","value":"18","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Need for Gastronomy Tube","description":"This is measured as Yes if a gastronomy tube was placed anytime prior to final status between birth and 60 days of life; Otherwise, No","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"6","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Duration of Oxygen Requirement","description":"This is measured as the number of days between birth and 60 days of life that an infant was on oxygen in the hospital.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"15.5","spread":null},{"groupId":"OG001","value":"18","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Need for Home Oxygen","description":"This is measured as Yes if an infant was discharged to home while on oxygen between birth and 60 days of life; Otherwise, No.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"4","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"Hospital Length of Stay","description":"This is measured as the number of days between birth and 60 days of life that an infant was in the hospital. Infants who died or transferred to another care facility were not included.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"27","spread":null},{"groupId":"OG001","value":"24","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Renal Insufficiency","description":"This is measured as Yes if an infant had renal insufficieny between birth and 60 days of life; Otherwise, No. Renal insufficiency is defined as creatinine less than 2 during 7 days after first treatment","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Necrotizing Enterocolitis","description":"This is measured as Yes if an infant necrotizing enterocolitis (NEC) between birth and 60 days of life; Otherwise, No. NEC could be proven with or without surgery","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"6","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Need for ECMO Therapy","description":"This is measured as Yes if an infant received ECMO treatment anytime between birth and 60 days of life; Otherwise, No. Extracorporeal membrane oxygenation (ECMO) is a treatment that uses a pump to circulate blood through an artificial lung back into the bloodstream of a very ill baby.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"6","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Inotrope Exposure","description":"This is measured as Yes if an infant was receiving inotropes on the specific day after the initiation of study drug.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"4","spread":null}]},{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"4","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"5","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]},{"type":"SECONDARY","title":"Inotrope Duration","description":"This is calculated as the number of days on inotropes starting 24 hours prior to initiation of study drug, during the 7-day study drug administration period, and for 3 days after the study drug.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]}]},{"type":"SECONDARY","title":"Maximum Inotrope Dose","description":"This is calculated as the maximum dose of all inotropes in the 10 days following the initiation of study drug administration. For the purposes of this calculation, dopamine and dobutamine doses were considered equivalent and 0.01 mcg/kg/min of epinephrine was equal to 5 mcg/kg/min of dopamine.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9.5","spread":"2.9"},{"groupId":"OG001","value":"14.7","spread":"12.6"}]}]}]},{"type":"SECONDARY","title":"Oxygenation Index","description":"This is calculated as fraction of inspired oxygen (FiO2), as a percentage, multiplied by the mean airway pressure divided by partial pressure of oxygen in arterial blood (PaO2), during study drug administration. A lower oxygenation index is better.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10.7","spread":"6.1"},{"groupId":"OG001","value":"14.5","spread":"8.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7","spread":"3.7"},{"groupId":"OG001","value":"14.9","spread":"6.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.6","spread":"2.1"},{"groupId":"OG001","value":"10.4","spread":"5.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.8","spread":"3"},{"groupId":"OG001","value":"9.2","spread":"4.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.7","spread":"2"},{"groupId":"OG001","value":"9.3","spread":"0.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.9","spread":"3.2"},{"groupId":"OG001","value":"7.9","spread":"1.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.7","spread":null},{"groupId":"OG001","value":"9.1","spread":"4.6"}]}]}]},{"type":"SECONDARY","title":"Respiratory Severity","description":"This is calculated as fraction of inspired oxygen (FiO2), as a percentage, multiplied by the mean airway pressure during study drug administration. Higher score means more severe.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"726.8","spread":"371"},{"groupId":"OG001","value":"1184.7","spread":"518.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"518.8","spread":"272.5"},{"groupId":"OG001","value":"1041.2","spread":"432.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"531.6","spread":"196.5"},{"groupId":"OG001","value":"925.8","spread":"611.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"414.6","spread":"230"},{"groupId":"OG001","value":"776.8","spread":"411.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"423","spread":"158.8"},{"groupId":"OG001","value":"899","spread":"453.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"323","spread":"117.8"},{"groupId":"OG001","value":"785.8","spread":"463.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"308.5","spread":"139.3"},{"groupId":"OG001","value":"694.7","spread":"274"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Fluid Boluses Given","description":"This is measured as Yes if an infant received fluid boluses anytime before or during study drug administration between birth and 60 days of life; Otherwise, No.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"2","spread":null}]},{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"4","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"5","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"6","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"4","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"6","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"6","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Boluses Given","description":"The number of fluid boluses given per participant, if any, before or during study drug administration between birth and 60 days of life","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG001","value":"1","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":6},"commonTop":["ATRIAL TACHYCARDIA"]}}}